Mutations in TP53 have previously been linked to genomic instability and progression of MDS to acute myeloid leukemia [4], but their impact on hemoglobinization and potential to contribute to the severity of macrocytic anemia in DBA and MDS patients remained unknown. The gene discussed is TP53; the disease is acute myeloid leukemia.